Investigation of treatment effects of KCC2-enhancing small molecule compounds in SYNGAP1 haploinsufficiency syndrome patient iPSC-derived neurons

Shilpa D. Kadam, Ph.D.
Axonis Therapeutics

Grant Number: 2023.1b
Funding Amount: $55,000
Percentage Disbursed: 100% Disbursed
Grant Status: Signed & active

See News Release Here.